Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Shibata, Yasushi*; Yamamoto, Kazuyoshi; Matsumura, Akira*; Yamamoto, Tetsuya*; Hori, Naohiko; Kishi, Toshiaki; Kumada, Hiroaki; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Nakai, Kei*; et al.
JAERI-Research 2005-009, 41 Pages, 2005/03
JAERI-Research-2005-009.pdf:1.99MB
The measurement of neutron flux and boron concentration in the blood during medical irradiation is indispensable in order to evaluate the radiation in boron neutron capture therapy. It is, however, difficult to measure the blood boron concentration during neutron irradiation because access to the patient is limited. Therefore we prospectively investigated the predictability of blood boron concentrations using the data obtained at the first craniotomy after infusion of a low dosage of BSH. When the test could not be carried out, the blood boron concentration during irradiation was also predicted by using the 2-compartment model. If the final boron concentration after the end of the infusion is within 95% confidence interval of the prediction, direct prediction from biexponential fit will reduce the error of blood boron concentrations during irradiation to around 6%. If the final boron concentration at 6 or 9 hours after the end of infusion is out of 95% confidence interval of the prediction, proportional adjustment will reduce error and expected error after adjustment to around 12%.
Kageji, Teruyoshi*; Nagahiro, Shinji*; Mizobuchi, Keiji*; Toi, Hiroyuki*; Nakagawa, Yoshinobu*; Kumada, Hiroaki
Applied Radiation and Isotopes, 61(5), p.1063 - 1067, 2004/11
Times Cited Count：9 Percentile：52.57(Chemistry, Inorganic & Nuclear)no abstracts in English
Yamamoto, Tetsuya*; Matsumura, Akira*; Nakai, Kei*; Shibata, Yasushi*; Endo, Kiyoshi*; Sakurai, Fumio; Kishi, Toshiaki; Kumada, Hiroaki; Yamamoto, Kazuyoshi; Torii, Yoshiya
Applied Radiation and Isotopes, 61(5), p.1089 - 1093, 2004/11
Times Cited Count：54 Percentile：94.61(Chemistry, Inorganic & Nuclear)no abstracts in English
Shibata, Yasushi*; Matsumura, Akira*; Yamamoto, Tetsuya*; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Nakai, Kei*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Hori, Naohiko; et al.
Research and Development in Neutron Capture Therapy, p.1055 - 1060, 2002/09
We prospectively investigated the predictability of blood boron concentrations using the data obtained at the first craniotomy after infusion of a low dose of sodium undecahydroclosododecaborate (BSH). Nine patients with malignant glial tumors underwent Boron neutron capture therapy (BNCT) at the Japan Atomic Energy Research Institute (JAERI) between 1995 and 2001. In 7 patients, 1g of BSH was infused before the first tumor removal and boron concentrations were determined using prompt gamma ray analysis (PGA). Then, 12 hours before BNCT, patients were infused at a dose of 100mg/kg BSH, and the boron concentrations were determined again. The boron biodistribution data showed a biexponential pharmacokinetic profile. If the final boron concentration at 6 or 9 hours after the end of the infusion is within the 95% confidence interval of the prediction, direct prediction from biexponential fit will reduce the error of blood boron concentrations during irradiation to around 6%.
Shibata, Yasushi*; Matsumura, Akira*; Yamamoto, Tetsuya*; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Nakai, K.*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Hori, Naohiko; et al.
Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, p.145 - 146, 2000/10
no abstracts in English
